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Healthcare workers want to listen more to patients and their carers in all sorts of areas
of healthcare. This can include choosing topics for medical research. We looked at how
patients and carers have helped to choose topics for research about type I diabetes.
We aimed to find out if, and why, researchers often rejected their choices. We looked at
a project which brought together patients, carers and healthcare workers to choose
topics for research about type 1 diabetes. The group first asked patients, carers and
healthcare workers to suggest ideas for research questions. But the group had to follow
rules about what counted as a good research question. Some people’s ideas did not
count as good research questions, and they were rejected at the start. We looked at
who were most likely to have their ideas rejected at the start. We found that patients
and carers were most likely to have a suggestion rejected. Then we looked at the
rejected questions in detail. They were mostly about curing diabetes, preventing
diabetes and understanding how diabetes works. There were also some questions
about access to medicines and the quality of care. Researchers should ask patients and
carers for help deciding what counts as a good research question from the start of
projects like these. We should also think about what might be getting in the way of
patients and carers making more of a difference in research.
Abstract
Background Patients and carers are increasingly involved in deciding on topics for
medical research. However, so far, it has been difficult to gain an accurate picture of the
impact of such involvement because of poor reporting and evaluation in published
studies to date. This study aimed to explore how a partnership of patients, carers,
healthcare professionals and organisations identified questions for future research
and why patients and carers had a limited impact on this process.
Methods In the first stage of the partnership process, relevant service users and
providers (including patients, carers, healthcare professionals and voluntary organisations)
were invited to submit suggested research questions about the treatment of type
1 diabetes, via a national online and paper survey. The partnership followed formal
protocols that defined a researchable question. This meant that many respondents’
suggested research questions were rejected at the start of the process. We analysed
survey submissions to find out which groups of respondents were most likely to have
their suggestions rejected and what these suggestions were about.
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Results Five hundred eighty-three respondents submitted 1143 suggested research
questions, of which 249 (21.8 %) were rejected at the first stage. Respondents with lived
experience of this long-term condition (patients and carers) were more likely than those
without lived experience to submit a research question that would be rejected (35.6 vs.
16.5 %; p < 0.0005). Among the rejected questions submitted by patients and carers,
there were several key themes: questions about cure, cause and prevention,
understanding the disease, healthcare policy and economics.
Conclusions In this case study, early decisions about what constituted a researchable
question restricted patients’ and carers’ contributions to priority setting. When
discussions about a project’s remit take place before service users are involved,
researchers risk distorting the potential impact of involvement. Impact assessments
should consider not only the differences patients and carers make to research but also
the differences they could have made in the absence of systemic barriers. We
recommend that initiatives aimed at involving patients and carers in identifying
research questions involve them as early as possible, including in decisions about
how and why suggested research questions are selected or rejected.
Keywords: Priority setting, Research priorities, Patient involvement, Patient and
carer involvement, PPI, Service-user involvement, Impact, Research agendaBackground
A major cause of medical research ‘waste’ is lack of attention to the real-world needs of
those who would benefit from research. This can be seen in the apparent mismatch be-
tween research agendas and the expressed needs of patients and carers [1, 2]. There
have been calls for this gap to be closed by inviting patients and carers to help shape
research priorities [1]. Similarly, it is argued that if healthcare services are to deliver
patient-centred care, then the evidence base provided by research needs to be more re-
flective of service users’ needs and concerns. Involvement of service users in identifying
and prioritising medical research questions and topics should help to ensure that re-
search being conducted is relevant to them. Such involvement can broaden the scope
of a proposed research agenda [2–4] and help to ensure that it is grounded in the day-
to-day reality of service users’ experiences [5].
In recent years, there has been a growth of academic literature (largely written by re-
searchers) reporting attempts to involve service users in identifying and prioritising re-
search questions [5, 4]. There is no agreed best practice for involving service users in
identifying priorities [6]; thus, a diverse range of processes is reported, including focus
groups, postal surveys, online questionnaires, social media forums, citizens’ juries,
workshops and informal communication [2, 3, 6–13]. The increasing use of formal
methods, however, provides growing opportunities for evaluations to investigate partici-
pants’ influence [14] and the barriers to and facilitators of such influence. Such evalu-
ation would help meet the growing demand for the impact of public involvement in
research to be measured in order to better understand what works for whom, in what
circumstances and why [15]. Unfortunately, poor and inconsistent reporting of patient
involvement and a lack of critical evaluation have made it difficult to gain an accurate
picture of the impact of patient involvement in research agenda setting, as in other
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measure impact that has occurred in a process designed by professionals, we may con-
clude that the service users have little to contribute, when in fact their influence may
be limited by the process itself. In other words, if we measure impact, are we just meas-
uring the extent to which service users are allowed to have an impact?
In this study, we sought to evaluate the unintentional barriers to impact of service
users, in this case patients and carers, on the identification of research questions during
the first stage of a James Lind Alliance Priority Setting Partnership for type 1 diabetes.
The James Lind Alliance (JLA), a non-profit-making UK initiative established in 2004,
facilitates Priority Setting Partnerships to bring together patients, carers and healthcare
professionals on an equal footing, identify unanswered questions about treatment
(‘uncertainties’) which are important to both groups, work with both groups jointly to
prioritise the uncertainties, and ultimately produce a ‘top 10’ list of jointly agreed un-
certainties as research questions to be presented to funders [16]. The Partnerships are
organised around patient conditions, such that the involved patients and carers have
‘lived experience’ of the condition under study. An increasing number of these Part-
nerships are being run across the UK [17], providing a means by which patients and
carers can potentially influence the agenda to better address their needs.Aims
We used the JLA Priority Setting Partnership for type 1 diabetes as a case study to (i)
explore differences between patients, carers and healthcare professionals with regard to
the likelihood of their identified research questions being outright rejected (i.e. not put
forward to the prioritisation stage) and (ii) explain these differences by analysing the
content of questions which were rejected. We aimed to co-produce this work by bring-
ing together our complementary expertise and experience in lived type 1 diabetes,
service-user involvement practice and qualitative and quantitative research methods.
We hope that our findings will increase understanding of the barriers to service users’
impact on the research agenda.
This study was fully approved by the Medical Sciences Interdivisional Research Ethics
Committee, University of Oxford.Methods
The methods of data collection and subsequent process for this Priority Setting Partnership
have been described more fully in a separate paper, which did not analyse those processes
[18]. The relevant methods from this original project are summarised below.The Priority Setting Partnership
The Partnership involved the following organisations: Juvenile Diabetes Research Founda-
tion, Insulin Dependent Diabetes Trust, Diabetes Research Network, Diabetes UK, Scottish
Diabetes Research Network, UK Database of Uncertainties in the Effects of Treatments and
the James Lind Alliance and NHS Evidence—diabetes. There were also individual members
with perspectives in paediatrics and primary care, as well as users of type 1 diabetes
services.
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formation specialist oversaw the whole Partnership process. They met three times face
to face and participated in five teleconferences throughout 2010 and 2011. The Insulin
Dependent Diabetes Trust provided core funding for the project, with other partners
contributing time and expertise in kind, including the production of survey materials
and distribution of update reports.Identifying potential research questions
The first step in the Partnership process was to identify potential research questions of
interest to service users and providers. A survey was developed (online and paper-
based) which asked, ‘What question(s) about the treatments for type 1 diabetes would
you like to see answered by research? (You can submit as many or as few as you like.)’
Questions were submitted anonymously as free text. Respondents were also asked to
state their relationship to type 1 diabetes, for example, whether they had the condition,
cared for someone with type 1 diabetes and/or worked as a diabetes specialist. Respon-
dents were allowed to tick more than one box. Members of the general public, that is,
those with no connection to type 1 diabetes, were not included in the exercise. Consent
to publish the questions provided by the survey was requested of all respondents. Only
questions from those who provided consent have been quoted in this study.
The survey was piloted with members of the steering group and their contacts, lead-
ing to several revisions before the final version was launched in 2010 (see Additional
file 1). The online survey ran from 10th March to 23rd May 2010 and was freely ac-
cessible online via a SurveyMonkey web link. All member organisations of the Partner-
ship promoted the survey and web link through widespread distribution of information
sheets, posters, postcards and flyers (see Additional files 2 and 3), targeting adults and
young people with type 1 diabetes, parents of children with type 1 diabetes and health-
care professionals with an interest in type 1 diabetes. The survey was also highlighted
to clinicians at the Diabetes UK annual professional conference in March 2010. Re-
spondents were recruited in this way by snowballing.Processing suggested research questions
Due in part to the nature of its funding, the Partnership had a strict protocol in place
to ensure that the exercise would establish interventional research priorities only, i.e.
those research questions that would inform treatment interventions. As a result, on
completion of the survey phase, an information specialist reviewed all the submitted
entries and discarded entries which were not concerned with the treatment of type 1
diabetes. Where in doubt, these decisions were checked by the steering group. The
steering group had access to a panel of people with type 1 diabetes, but there were no
patient representatives on the steering group itself at this early stage, a situation which
was acknowledged as being less than ideal. One of the authors of this paper, RS, be-
came involved in the later stages as a patient representative.Our evaluation methods
Building on this original project, we used the data collected by the JLA for a mixed
methods analysis with an explanatory sequential design [19]. We began by examining
Snow et al. Research Involvement and Engagement  (2015) 1:7 Page 5 of 13measurable differences between patients, carers and healthcare professionals in terms
of the likelihood of their suggested research questions being rejected. We then sought
to shed further light on these differences by analysing the content of the rejected sug-
gestions using qualitative methods.
Quantitative data analysis
Respondents were coded according to whether or not they had submitted a question
which was then rejected and how they had classified their role or relationship with dia-
betes. Some respondents had dual roles (for example, a person with type 1 diabetes
who also had a child with the condition) and were coded positive for each of these cat-
egories. Respondents who classified themselves as patients and/or carers were addition-
ally coded as having ‘lived experience’ of type 1 diabetes.
Data were analysed using IBM SPSS Statistics 22. For each respondent group, we cal-
culated the proportion of respondents who submitted a question that was later rejected.
Cross-tabulations were used to examine differences in terms of the likelihood of sub-
mitting a question that was subsequently rejected outright between the following re-
spondent groups: (a) ‘lived experience’ vs. no ‘lived experience’, (b) healthcare
professionals vs. non-healthcare professionals and (c) patients vs. carers (within the
‘lived experience’ category). We did not directly compare patients and carers with
healthcare professionals because there was substantial overlap between these roles
(33 % of healthcare professionals were also patients or carers).
Qualitative data analysis
The aim of qualitative analysis was to gain insight into the kinds of patient and carer
(‘lived experience’) submissions that were rejected.
All rejected submissions from carers and patients were analysed by two researchers:
JC, an expert in patient involvement but with no relevant experience of long-term con-
ditions, and RS, a service-user-researcher with lived experience of type 1 diabetes.
Working individually, JC and RS each developed a coding framework based on emer-
gent themes from the full range of rejected submissions [20]. These interpretations
were then compared, discussed and refined until agreement was reached. In a subse-
quent coding process, themes were grouped into four overarching categories: research-
able issues, information about research, personal issues and unclear questions. Data
within the large ‘researchable issues’ category were further indexed by theme, with sub-
missions frequently indexed under multiple themes. The quotations in this paper have
been specifically chosen to illustrate the categories and themes that emerged from this
analysis.Co-creation of this study
The research question, design of this study and analysis of existing JLA data were
entirely co-created by researchers with relevant skills: JC, a specialist in impact assess-
ment of patient involvement and quantitative data analysis, and RS, a service-user-
researcher specialising in qualitative analysis, who has over 25 years experience of living
with and self-managing type 1 diabetes. The process of bringing these varied perspec-
tives to a collaborative analysis and discussion of the data was invaluable. Both
researchers contributed equally to the project; all elements of the study have therefore
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this as a wholly positive partnership based on respect and a genuine interest in each
others’ perspectives. SC, who facilitated the original Partnership, acted as advisor to this
study and contributed to the write-up of this article along with RS and JC. A lay con-
tributor with over 20 years of experience and qualifications in child and adult education
reviewed and revised the article, improving its sense and accessibility to lay readers. As
a result of her revisions alone, the Gunning Fog Index (a measure of readability) of the
“Plain English summary” decreased from 12.95 to 9.73.Results
Likelihood of submitting a rejected question: differences between respondent groups
A total of 1143 suggestions were submitted by 583 respondents. Each respondent sub-
mitted between 1 and 20 suggestions (median 1 suggestion).
By far the largest participating group was people with type 1 diabetes (Table 1).
Ninety-nine (17.0 %) respondents classified themselves as having more than one role
(patient, carer, healthcare professional, organisation and/or other).
Two hundred and forty-nine (21.8 %) suggestions from 190 (32.6 %) respondents
were classified as ‘not a treatment uncertainty’ and were therefore rejected from further
stages of the priority-setting process (Table 2).
Respondents with lived experience of type 1 diabetes were significantly more likely to have
submitted a question that would be rejected, compared to respondents without lived experi-
ence of the condition (Table 3). Moreover, respondents who were healthcare professionals
were significantly less likely to have submitted a question that would be rejected, compared
to respondents who were not healthcare professionals (Table 4). Among respondents with
lived experience of type 1 diabetes, carers were significantly more likely than patients to
have submitted a question that would be rejected (Table 5).Rejected questions submitted by respondents with lived experience of type 1 diabetes
The themes that emerged from qualitative analysis of the rejected suggestions from
patients and carers were grouped broadly into four categories: researchable issues,
research progress, personal issues and unclear questions. In the examples given, all
submissions are provided verbatim, with no alterations to the original punctuation or
spelling.Table 1 Respondent roles (N = 583)
Role Total (N) N with exclusive role
Patienta 401 (68.8 %) 342 (58.7 %)
Carer 108 (18.5 %) 80 (13.7 %)
Healthcare professional 96 (16.5 %) 60 (10.3 %)
Organisation 30 (5.1 %) 2 (0.3 %)
Otherb 33 (5.7 %) 24 (4.1 %)
aPeople who identify themselves as having type 1 diabetes
bIncluding researchers (N = 4), people who identify as having a health condition other than type 1 diabetes (N = 2),
people who work in health education (N = 2), people who work in the health service but do not identify themselves as
healthcare professionals (N = 1) and people who provided no additional information (N = 24)
Table 2 Number of rejected questions, by respondent role (N = 249)
Role Number of rejected
questions submitted
Number of rejected questions submitted
by respondents with exclusive role
Patienta 171 (68.7 %) 143 (57.4 %)
Carer 68 (27.3 %) 58 (23.3 %)
Healthcare professional 27 (10.8 %) 10 (4.0 %)
Organisation 7 (2.8 %) 0 (0.0 %)
Otherb 11 (4.4 %) 4 (1.6 %)
aPeople who identify themselves as having type 1 diabetes
bIncluding a researcher (N = 5), person who identifies as having a health condition other than type 1 diabetes (N = 1),
person who works in health education (N = 1) and people who provided no additional information (N = 4)
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A small number of submitted questions covered researchable treatment uncertainties to
which the answer was ‘already known’, that is, research had already been done and an-
swers found. However, because the JLA protocol dictated that only ‘treatment
uncertainties’ should be considered, a far greater number of potentially researchable sug-
gestions were rejected on the basis that they were not considered to be about ‘treatments’.
Cure
A substantial subsection of these researchable issues was concerned in some way with re-
search for a cure. Although it is difficult to give precise numbers due to issues with wording
(discussed below), 13.7 % (34 out of 249) of rejected questions from patients and carers spe-
cifically mentioned the word ‘cure(s)’ or ‘cured’, while others made suggestions that could be
interpreted as associated with cure research, such as, ‘Will type 1 diabetes ever be solved’.
Broad cure questions (for example, ‘can we find a cure?’) were submitted only by those with
lived experience of the condition and were routinely rejected. However, when patients and
carers came together with healthcare professionals for the final prioritisation workshop in
the Partnership process, they expressed concern at the absence of cure questions and asked
to include a version of these questions. The Partnership thus reinstated it as an ‘overarching’
priority, although its wording was altered to specify a particular area of research: ‘is stem cell
therapy an effective treatment⁄cure?’ [18]. ‘Cure’ was the only type of question reprieved in
this way.
Cause and prevention
Questions about the cause of the disease, and also its prevention, were rejected. Along-
side broad requests for research into cause and prevention, some suggested specific
environmental factors to explore, such as the use of particular drugs, the presence of
pollutants and links with other diseases.
What causes, and therefore leading to what could prevent, type 1 diabetes
Is the cause of type 1 diabetes linked to the use of inhaled steroid asthma inhalers?Table 3 Association between lived experience and submission of at least one rejected question (N= 583)
Submitted a question that was rejected p value
Lived experiencea 175/492 (35.6 %) <0.0005
No lived experience 15/91 (16.5 %)
aPatients and/or carers, 32/492 (6.5 %) of whom were also healthcare professionals
Table 4 Association between healthcare professional role and submission of at least one rejected
question (N = 583)
Submitted a question that was rejected p value
Healthcare professionalsa 22/97 (22.7 %) 0.023
Non-healthcare professionals 168/486 (34.6 %)
aHealthcare professionals, 32/97 (33.0 %) of whom were also patients and/or carers
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hypersensitivity e.g. asthma, peanut allergies etc.?
Understanding disease
A broad subcategory of the researchable issues rejected fell into the category
of ‘understanding disease’. These included research that would help day-to-day
self-management: understanding unknown factors that affect fluctuations in
blood glucose, investigating risk factors for particular complications in addition
to ordinary blood glucose control and looking at the reasons behind particular
symptoms or responses to high and low blood glucose.
How can one prevent the liver from producing glucose in stressful situations (when
adrenaline is produced)?
Identifying genetics factors associated with early/ late progression to complications
Why do different people react differently to extreme hypos eg/ unconsciousness,
coma, seizures?
Practice and policy
A further subset of questions addressed broader issues such as quality of care, inequal-
ities in care and access to treatment rather than treatments themselves.
Why is advice not the same depending on where you live in the Uk
Why are some hospitals more than others keener on insulin pumps?
Why is there a difference in the UK’s approach to diabetes so different to USA’s?
How many people with diabetes are on an insulin regimen that they feel works for
them?
This category also included a number of questions that raised issues around the way
people with diabetes are treated by others, including policy makers, healthcare profes-
sionals and the general public. For example:
One reads over time […] quite a lot of discrimination against sufferers. It would
perhaps seem by “research” methods that this discrimination is uncalled for and
could actively be demonstrated to be unfair.Table 5 Association between patient vs. carer role and submission of least one rejected question
(N = 475)a
Submitted a question that was rejected p value
Patient (not carer) 129/384 (33.6 %) 0.025
Carer (not patient) 49/91 (53.8 %)
a17 (2.9 %) respondents with a dual patient and carer role were excluded from this analysis
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Exploration of the policy and economics behind healthcare research and investigation into
vested interests that might be slowing research progress were also recurring themes in the
rejected questions:
Does type 1 diabetes still exist because there is an investment in keeping the disease
going from drug manufacturers?
Why couldnt the Insulin pumps be redeisgned so they are MUCH MUCH LESS
EXPENSIVE?
Why it seems to be that advances in this field in treatment, devices as well as in
understanding where the disease come from are incredibly slow compared with
engineering advances
Information about research
Not every rejected suggestion contained a question that could be researched. Some were
direct requests for information about the process of research or about progress of existing
research:
Can more information about the clinical stages of research & trials be explained
What UK in particulary is doing as research for people living with this condition?
Some of these submissions could be considered as prioritising certain areas for research,
although they were formulated as questions about existing progress. Thus, the example
below might be counted as requesting research into a cure or literally asking for an estimate
of the amount of time before a cure can be found:
How soon, realistically, will there be a cure for Type i diabetes?
Personal issues
A very small number of submissions contained direct questions about issues personal
to the respondent’s history or treatment:
What kind of insulin am I on eg Animal?
Again, some of these could have been interpreted more generally, such as the
question below, in which the respondent could be asking about specific family circum-
stances, but could also be raising a more general question about the cause of the disease:
Why did I develop type 1 at 15 (now 65) & my brother at 19 (now 62) with no history
in family
Unclear questions or no question at all
Finally, a few submissions were so broad or difficult to interpret that it was impossible
to categorise them with any certainty; some participants openly declared that they did
not have a question to submit:
diet and insulin giving more freedom then it does now
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There were also a small number of personal offers to volunteer as a research partici-
pant, which were not followed up.Discussion
This mixed methods analysis has highlighted a number of important issues to consider
when deciding how to involve patients and carers in research priority setting and how
to assess the impact of that involvement. Even within the well-respected JLA model ex-
amined here, in which involvement takes place in nearly all aspects of the priority-
setting process, early decisions about the way questions were framed and what counted
as viable suggestions unintentionally reduced patients’ and carers’ potential impact.
In particular, researchers wishing to include lay perspectives should be aware of as-
suming a shared understanding of the concepts under discussion. In this case study,
participants were asked to identify uncertainties about the effects of treatment for dia-
betes, with the explicit aim of ensuring that the final priority list could be included in a
national database available to future researchers and funders [18]. While this had obvi-
ous practical advantages, it also had the effect of disempowering respondents with lived
experience of type 1 diabetes, and non-healthcare professionals, who were significantly
less likely than other respondent groups to contribute research priorities that fit that
model.
Analysis of the rejected submissions suggests that ‘treatment’ meant something differ-
ent to those with lived experience of a chronic condition and that the narrow, medical
definition of ‘treatment’ was inadequate to cover the range of other questions which
patients and carers wished to raise as priorities for research. Those living with a serious
condition regarded it important to initiate research into fair access to treatment (and
cure) as well as into the treatment itself. In addition, for patients, treatment may mean
‘the way one is treated’ by others, particularly those with authority or power. It could
be argued that the lines between what is a treatment and what is not are much more
grey for patients, when a long-term condition is part of every aspect of life, rather than
for healthcare professionals or researchers, where it is merely part of one’s working life.
To take a hypothetical example, if the effective use of an insulin pump is bound up
with how easy it is to get a prescription for that pump, how one’s body reacts to the de-
livery system in the pump and the way society responds to the person who wants to
use the pump, then categorising research priorities by the pump alone conflates many
different issues in the lived experience of patients and carers.
A final issue for those engaging with non-researchers in order to develop research
questions is to consider what to do with additional requests for information or offers of
help. Without a strategy to respond to this kind of submission, valuable opportunities are
lost to engage patients in research, answer their questions and make them feel valued.
Our findings are consistent with other priority-setting studies both in the UK and
internationally, in which patients have identified a broader range of topics than profes-
sionals, including questions related to the environment, psychosocial issues, patient-
clinician relationships and service provision [2, 8, 10, 12, 13]. All of these issues, as well
as many of those identified in our case study, could be addressed in some way by differ-
ent disciplines within the broad field of healthcare research, including sociology,
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interpreting service users’ responses to open-ended questions when there is no oppor-
tunity for dialogue or clarification [6]. Such issues may be confounded by service users’
unfamiliarity with research and research programmes’ unfamiliarity with service users
[21], risking the unintended distortion or loss of impact. Oliver and colleagues propose
that investing time and effort in good communication, training and support should help
to overcome this barrier [21]. It could also be argued that service users’ challenge to
the concept of what counts as a valid research question is in itself valuable.
In some participatory models of research priority setting, no contributions are
rejected without patient influence [12, 13]. The inclusion of service users in rejection
decisions could help to close the gap between respondents’ suggestions and the inter-
pretation of these suggestions, as well as increasing their potential impact. In many
cases, however, the process by which service users’ suggestions are accepted or rejected
is not described or explained and remains a ‘black box’ [22–25]. In the original Priority
Setting Partnership, the anonymity of survey submissions meant that further direct dia-
logue with participants was not possible.
It should be noted that since the completion of the type 1 diabetes project, the JLA
itself has made a number of methodological changes to its protocol, including widening
of the scope beyond therapeutic research questions, inclusion of the concept of ‘cure’
research and earlier discussion with patients and carers in steering groups about exclu-
sion criteria [16].
A limitation of this study is its focus on a single-question format (‘treatment uncer-
tainties’), single-priority-setting method (the JLA Priority Setting Partnership) and a
single condition (type 1 diabetes). We were also unable to adjust for respondent charac-
teristics (e.g. age, ethnicity, education level and socioeconomic status) in our quantita-
tive analysis, as reliable information about these variables was not collected during the
original project. It is possible that the observed associations between respondent role
and questions being rejected were confounded by such characteristics, and future stud-
ies should investigate whether these factors independently influence the impact that
patients and carers are able to have.
Conclusions
This study raises important concerns that are applicable to other service-user involve-
ment initiatives internationally.
Firstly, decisions must always be made at the very start of any research project about
its remit, what to include and exclude, and what counts as a legitimate topic for discus-
sion. When these decisions take place before patients and/or carers are involved,
researchers may be creating research boundaries which service users might not agree
with. They therefore risk limiting or distorting the impact of service-user involvement
because the latter’s contribution may not ‘fit’ their pre-determined framework. We rec-
ommend that those assessing the impact of service-user involvement examine not only
the differences patients and carers make to research but also the impact they could
have had in the absence of systemic barriers. Without this, it is all too easy to jump to
misleading conclusions that service users have no or minimal impact.
Secondly, if such boundaries do have to be created before service users are involved,
it is important to define them clearly in accessible language so that service users can
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tributions are rejected, it is important to be transparent about how those decisions are
being made and by whom.
Finally, we recommend that service-user involvement initiatives, including research
priority-setting partnerships, involve service users as early as possible in collaborative
decisions about their design and remit, in order to maximise the potential impact of
their contributions. This could lead to service users challenging the very definition of a
‘research question’ and what counts as evidence, and we feel this would be an open
debate worth having, mutually beneficial to both service users and researchers in the
long run.
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